These results are consistent with the presence of an active Wnt signaling pathway in this cells [20], [26], [35], [36], and support the rationale for testing the pharmacological stabilization of Axin1, which might have clinical relevance for treatment of certain sarcoma sub-types. This evidence concerns the gene AXIN1 and sarcoma.